Head-to-head · Cost-Efficiency Index
Rewinding RX vs VirtualCare2Go
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rewinding RX
Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line.
Visit Rewinding RXVirtualCare2Go
Shoppers near Dallas-Fort Worth who want a bundled per-visit price rather than a per-drug breakdown.
Visit VirtualCare2GoThe verdict
Rewinding RX and VirtualCare2Go tie on the Cost-Efficiency Index at 66/100, so neither wins outright on the numbers. For most shoppers we'd start with Rewinding RX (ranked #150, a hair above #154) — Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line. But VirtualCare2Go is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Rewinding RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rewinding RX | VirtualCare2Go |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 66/100 |
| Semaglutide / mo | $139/mo (microdose tier, compounded) | $279/mo (bundle, compounded) |
| Tirzepatide / mo | $189/mo (microdose tier, compounded) | $629/mo (bundle, compounded) |
| Semaglutide / yr (modeled) | $1,668 | $3,348 |
| Tirzepatide / yr (modeled) | $2,268 | $7,548 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #150 | #154 |
Rewinding RX
66/100Where the value is
- Flat pricing within each product regardless of dose
- Publishes the FDA compounded-medication disclaimer and states pharmacies are '503A'/'503B' FDA-regulated facilities
- Corporate entity is disclosed (Rewinding RX Ltd.)
The tradeoffs
- Four separate GLP-1 SKUs exist at four different prices under similar names
- No compounding pharmacy is individually named, only generic '503A'/'503B' language
VirtualCare2Go
66/100Where the value is
- Three distinct price points let a budget-conscious shopper choose compounded ($279) over the bundled injection tier ($629)
- A stand-alone $99.99 consult-only option exists for shoppers who want to fill the prescription at their own pharmacy
- Clear plain-language inclusion statements (consultation, medication, shipping) attached to each tier
The tradeoffs
- The $629 'Weight Loss Injections' tier prices semaglutide, liraglutide, and tirzepatide identically and does not disclose whether tirzepatide specifically costs more — a real gap for a comparison site trying to isolate a tirzepatide price
- No LegitScript badge found anywhere on the site, where the other rows in this batch carry one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.